New Delhi, August 20:
Johnson & Johnson has submitted an application to the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of its vaccine against the coronavirus (Covid-19) disease in India among adolescents aged 12-17 years.
In a statement released on Friday, the American pharmaceuticals company reportedly said it had submitted its application on Tuesday. It further said it was “imperative” to ensure all sections of the population, including children, were vaccinated against the virus at the earliest.
“To ultimately achieve herd immunity it is imperative that COVID-19 vaccine clinical trials continue to move forward in this population, and we remain deeply committed to the critical work needed to make our COVID-19 vaccine equitably accessible for all age groups,” the statement added.
The government had earlier said, inoculation of children against the virus is likely to begin by September. On Thursday, Bharat Biotech’s managing director Krishna Ella said the trial phase of clinical studies in volunteers in the 2-18 age group has been completed.
